Analysis on influencing factors of length of hospital stay in a multicenter heart failure cohort

Acta Universitatis Medicinalis Anhui 2022 10 v.57 1665-1669     font:big middle small

Found programs:

Authors:Xu Ruochen; Chen Kangyu; Wang Qi; Wu Guohong; Su Hao; Liu Fuyuan; Li Hongqi; Yan Ji

Keywords:heart failure;hospitalization time;influencing factors

DOI:10.19405/j.cnki.issn1000-1492.2022.10.028

〔Abstract〕 Objective To analyze the length of hospital stay of patients with heart failure in a multicenter cohort in order to explore the influencing factors of length of stay and provide data support for further intervention. Methods A total of 2 794 patients enrolled in the multicenter prospective heart failure cohort were divided into two groups: long hospital stay group(≥9 days) and short hospital stay group(<9 days). The general data of the two groups were compared, and the factors with statistical difference in univariate analysis were included in Logistic multifactor regression analysis to explore the difference in length of hospital stay between the two groups. According to left ventricular ejection fraction(LVEF), patients were divided into heart failure with preserved reduced ejection fraction(HFpEF)group, heart failure with mildly reduced ejection fraction(HFmrEF)group and heart failure with reduced ejection fraction(HFrEF) group, and Logistic multifactor regression analysis was performed to find influencing factors. Results Logistic multifactor regression analysis showed that LVEF, pneumonia, N-terminal pro-B-type natriuretic peptide(NT-proBNP), serum sodium, cardiac resynchronization therapy(CRT)or implantable cardioverter defibrillator(ICD)implantation, β blockers, aldosterone receptor antagonists, positive inotropic drugs and vasodilators were all factors influencing the hospitalization of HF patients. In the HFpEF, HFmrEF, and HFrEF groups, CRT/ICD implantation, positive inotonic drugs, and vasodilator use were suggested to be common factors affecting length of hospital stay in all three groups. Conclusion LVEF, pneumonia, NT-proBNP, serum sodium, CRT or ICD implantation, β blockers, aldosterone receptor antagonists, positive inotropic drugs and vasodilators are the influencing factors of hospitalization time in HF patients.